NYSE:BAX - Baxter International Stock Price, Price Target & More

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Baxter International announced a quarterly dividend on Tuesday, July 17th. Investors of record on Friday, August 31st will be given a dividend of $0.19 per share on Monday, October 1st. This represents a $0.76 dividend on an annualized basis and a dividend yield of 1.01%. The ex-dividend date is Thursday, August 30th. View Baxter International's Dividend History.

Baxter International declared that its Board of Directors has initiated a stock buyback plan on Wednesday, February 21st 2018, which allows the company to repurchase $1,500,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to reacquire shares of its stock through open market purchases. Stock repurchase plans are typically a sign that the company's board believes its shares are undervalued.

Baxter International Inc (NYSE:BAX) issued its quarterly earnings data on Thursday, April, 26th. The medical instruments supplier reported $0.70 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.62 by $0.08. The medical instruments supplier earned $2.68 billion during the quarter, compared to the consensus estimate of $2.62 billion. Baxter International had a net margin of 7.75% and a return on equity of 15.70%. The company's quarterly revenue was up 8.2% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.58 EPS. View Baxter International's Earnings History.

Baxter International is scheduled to release their next quarterly earnings announcement on Thursday, July, 26th 2018. View Earnings Estimates for Baxter International.

Baxter International issued an update on its FY18 earnings guidance on Thursday, April, 26th. The company provided EPS guidance of $2.85-2.93 for the period, compared to the Thomson Reuters consensus estimate of $2.78. The company issued revenue guidance of $11.3-11.4 billion, compared to the consensus revenue estimate of $11.25 billion.Baxter International also updated its Q2 guidance to $0.69-0.71 EPS.

16 analysts have issued 1-year target prices for Baxter International's shares. Their predictions range from $62.00 to $83.00. On average, they anticipate Baxter International's share price to reach $72.7333 in the next twelve months. This suggests that the stock has a possible downside of 3.0%. View Analyst Ratings for Baxter International.

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 6 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Some companies that are related to Baxter International include 3M (MMM), Becton Dickinson and (BDX), Stryker (SYK), Boston Scientific (BSX), FRESENIUS SE &/S (FSNUY), ABIOMED (ABMD), ResMed (RMD), Teleflex (TFX), DexCom (DXCM), Hill-Rom (HRC), ICU Medical (ICUI), Insulet (PODD), Haemonetics (HAE), Globus Medical (GMED) and Penumbra (PEN).

Media stories about BAX stock have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research firm identifies negative and positive news coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Baxter International earned a coverage optimism score of 0.20 on Accern's scale. They also gave news headlines about the medical instruments supplier an impact score of 47.78 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the next several days.

Baxter International's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Calamos Advisors LLC (0.25%), Bank of Montreal Can (0.11%), Gateway Investment Advisers LLC (0.08%), Huntington National Bank (0.08%), Boston Advisors LLC (0.07%) and NN Investment Partners Holdings N.V. (0.05%). Company insiders that own Baxter International stock include Albert P L Stroucken, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Institutional Ownership Trends for Baxter International.

BAX stock was sold by a variety of institutional investors in the last quarter, including NN Investment Partners Holdings N.V., Bank of Montreal Can, Assenagon Asset Management S.A., Hartford Investment Management Co., Ipswich Investment Management Co. Inc., Westpac Banking Corp, Gateway Investment Advisers LLC and Tokio Marine Asset Management Co. Ltd.. Company insiders that have sold Baxter International company stock in the last year include Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Insider Buying and Selling for Baxter International.

BAX stock was purchased by a variety of institutional investors in the last quarter, including Sit Investment Associates Inc., Handelsbanken Fonder AB, Boston Advisors LLC, Cornerstone Wealth Management LLC, Huntington National Bank, Calamos Advisors LLC, Municipal Employees Retirement System of Michigan and Gulf International Bank UK Ltd. View Insider Buying and Selling for Baxter International.

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of BAX stock can currently be purchased for approximately $75.00.

Baxter International has a market capitalization of $40.02 billion and generates $10.56 billion in revenue each year. The medical instruments supplier earns $717 million in net income (profit) each year or $2.48 on an earnings per share basis. Baxter International employs 47,000 workers across the globe.

Baxter International's mailing address is One Baxter Parkway, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]